Brexogen, a leading biotechnology company specialising in exosome-based therapeutics, has announced a technology transfe...
Oita University and Eisai Co., in Japan, have announced the development of a machine learning model to predict amyloid b...
Indian pharmaceutical firm Zydus Lifesciences has announced that its wholly owned subsidiary, Zydus Lifesciences...
South Korea-based Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides ...
A new breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free surviva...
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimise ...
India-based Zydus Lifesciences (including its subsidiaries and affiliates), has signed an exclusive development, licensi...
Daewoong Pharmaceutical, a leading healthcare company in Korea, has announced the official launch of its high-purity, hi...
AdvanCell, a radiopharmaceutical company specialising in targeted alphaherapias, has announced the expansion of the scop...
Bowtie, Hong Kong’s first virtual insurer, has collaborated with Gleneagles Hospital Hong Kong and Pfizer Hong Kon...
South Korea-based OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced a global licensing...
Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on ...
Bain Capital, a leading global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe P...
Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of India-based Dr. Reddy’s Laboratories Ltd. has entere...
US-based ValGenesis Inc., the global leader in enterprise validation lifecycle management systems (VLMS), and Hitachi In...
South Korea-based Hyundai Bioscience, and the Drugs for Neglected Diseases initiative (DNDi), an international non-profi...
Hikma Pharmaceuticals PLC, a British pharmaceutical group, has signed a strategic memorandum of understanding (MoU) with...
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer treatments, has closed an oversubsc...
